MacroGenics, Inc. (MGNX) has a negative trailing P/E of -2.8, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. Trailing earnings yield is -35.53%.
Criteria proven by this page:
Overall SharesGrow Score: 43/100 with 2/7 criteria passed.
| Year | P/E (TTM) | PEG Ratio | P/B Ratio | P/S Ratio | Dividend Yield |
|---|---|---|---|---|---|
| 2016 | -12.1 | -0.07 | 2.64 | 8.19 | - |
| 2017 | -34.9 | 0.51 | 2.29 | 4.41 | - |
| 2018 | -3.0 | 0.00 | 2.14 | 8.65 | - |
| 2019 | -3.4 | 0.14 | 2.27 | 8.43 | - |
| 2020 | -9.2 | 0.32 | 4.05 | 12.26 | - |
| 2021 | -4.8 | -0.12 | 4.02 | 12.72 | - |
| 2022 | -3.4 | 0.09 | 2.90 | 2.75 | - |
| 2023 | -65.8 | 0.71 | 3.90 | 10.42 | - |
| 2024 | -3.0 | 0.00 | 1.75 | 1.37 | - |
| 2025 | -1.4 | -0.13 | 1.83 | 0.68 | - |
| Year | EPS (Diluted) | Revenue | Net Income | Net Margin |
|---|---|---|---|---|
| 2016 | $-1.69 | $86.58M | $-58.53M | -67.6% |
| 2017 | $-0.54 | $155.52M | $-19.63M | -12.6% |
| 2018 | $-4.19 | $60.12M | $-171.45M | -285.2% |
| 2019 | $-3.16 | $62.02M | $-151.81M | -244.8% |
| 2020 | $-2.25 | $97.76M | $-117.78M | -120.5% |
| 2021 | $-3.18 | $75.64M | $-190.86M | -252.3% |
| 2022 | $-1.95 | $151.94M | $-120.02M | -79% |
| 2023 | $-0.15 | $57.19M | $-9.06M | -15.8% |
| 2024 | $-1.07 | $148.34M | $-66.97M | -45.1% |
| 2025 | $-1.18 | $149.5M | $-74.62M | -49.9% |
| Year | EPS (Avg) | EPS Range | Revenue (Avg) | Revenue Range | Analysts |
|---|---|---|---|---|---|
| 2026 | $-1.64 | $-2.76 – $-0.25 | $100.4M | $32.51M – $173.93M | 3 |
| 2027 | $-1.59 | $-1.85 – $-1.33 | $98.59M | $75.1M – $122.07M | 2 |
| 2028 | $-2.48 | $-3.35 – $-1.60 | $113.52M | $53.22M – $190.8M | 2 |
| 2029 | $-2.20 | $-4.15 – $-0.68 | $120.54M | $56.51M – $202.61M | 1 |
| 2030 | $-1.63 | $-3.07 – $-0.50 | $153.09M | $71.77M – $257.32M | 1 |
